tiprankstipranks
Advertisement
Advertisement

AMGN Stock Latest News

Midday Fly By: AT&T reports Q2 beat, AMD invests $5B in Anthropic
The FlyMidday Fly By: AT&T reports Q2 beat, AMD invests $5B in Anthropic
3d ago
T
PM
Amgen reaches $74M lawsuit settlement over tax bill, Reuters reports
PremiumThe Fly
Amgen reaches $74M lawsuit settlement over tax bill, Reuters reports
3d ago
AMGN
Amgen Halts Bemarituzumab Gastric Cancer Trial, Shifting Oncology Expectations
PremiumCompany Announcements
Amgen Halts Bemarituzumab Gastric Cancer Trial, Shifting Oncology Expectations
8d ago
AMGN
Amgen Advances Obesity Pipeline With Fresh Data on AMG 133 Injection Formats
PremiumCompany Announcements
Amgen Advances Obesity Pipeline With Fresh Data on AMG 133 Injection Formats
9d ago
AMGN
Amgen’s Rocatinlimab Eczema Trial Termination Jolts Investor Expectations
PremiumCompany Announcements
Amgen’s Rocatinlimab Eczema Trial Termination Jolts Investor Expectations
9d ago
AMGN
Wolfe cuts Ionis Pharma to Peer Perform after disappointing trial data
PremiumThe FlyWolfe cuts Ionis Pharma to Peer Perform after disappointing trial data
10d ago
AMGN
IONS
Amgen price target raised to $420 from $400 at UBS
Premium
The Fly
Amgen price target raised to $420 from $400 at UBS
12d ago
AMGN
Amgen price target raised to $312 from $307 at BofA
Premium
The Fly
Amgen price target raised to $312 from $307 at BofA
12d ago
AMGN
Amgen price target raised to $343 from $340 at Guggenheim
PremiumThe Fly
Amgen price target raised to $343 from $340 at Guggenheim
12d ago
AMGN
Analyst Maintains Sell on Amgen as Shares Trade Above Newly Raised $312 Price Target and Near-Term Growth Remains Limited
PremiumRatings
Analyst Maintains Sell on Amgen as Shares Trade Above Newly Raised $312 Price Target and Near-Term Growth Remains Limited
12d ago
AMGN
Amgen price target lowered to $333 from $340 at Morgan Stanley
PremiumThe Fly
Amgen price target lowered to $333 from $340 at Morgan Stanley
17d ago
AMGN
Amgen price target raised to $340 from $327 at Truist
PremiumThe Fly
Amgen price target raised to $340 from $327 at Truist
18d ago
AMGN
Amgen’s Rocatinlimab Asthma Trial Reaches Phase 2 Finish Line
PremiumCompany AnnouncementsAmgen’s Rocatinlimab Asthma Trial Reaches Phase 2 Finish Line
23d ago
AMGN
Amgen’s AMG 133 Trial Adds a New Data Point in the Obesity Drug Race
Premium
Company Announcements
Amgen’s AMG 133 Trial Adds a New Data Point in the Obesity Drug Race
24d ago
AMGN
Amgen Refines Its PCSK9 Franchise with New Evolocumab Bioavailability Study
Premium
Company Announcements
Amgen Refines Its PCSK9 Franchise with New Evolocumab Bioavailability Study
24d ago
AMGN
CodeBreaK 100: Amgen’s KRAS Trial Update and What It Means for AMGN Investors
PremiumCompany Announcements
CodeBreaK 100: Amgen’s KRAS Trial Update and What It Means for AMGN Investors
25d ago
AMGN
Trial used to approve Amgen’s Tavneos retracted from NEJM
PremiumThe Fly
Trial used to approve Amgen’s Tavneos retracted from NEJM
26d ago
AMGN
Why Schwab U.S. Dividend Equity ETF (SCHD) Could Jump 15%, According to AI
PremiumMarket News
Why Schwab U.S. Dividend Equity ETF (SCHD) Could Jump 15%, According to AI
29d ago
MRK
UNH
Midday Fly By: Micron reports blowout Q3, Apple boosts MacBook prices
PremiumThe Fly
Midday Fly By: Micron reports blowout Q3, Apple boosts MacBook prices
30d ago
BB
GS
FDA works to pull Amgen’s Tavneos off the market, Bloomberg says
PremiumThe FlyFDA works to pull Amgen’s Tavneos off the market, Bloomberg says
1M ago
AMGN
Amgen price target raised to $303 from $295 at Mizuho
Premium
The Fly
Amgen price target raised to $303 from $295 at Mizuho
1M ago
AMGN
Amgen’s ABP 938 Takes Aim at EYLEA HD in High-Stakes Eye Disease Trial
Premium
Company Announcements
Amgen’s ABP 938 Takes Aim at EYLEA HD in High-Stakes Eye Disease Trial
1M ago
AMGN

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >